US doses arrive as Nepal struggles to vaccinate population
A shipment of 1.5 million doses of Johnson and Johnson vaccine donated by the United States arrived Monday in Nepal, which is struggling to inoculate its population against the coronavirus. “Today's delivery of the single-dose vaccine means that this single donation is enough to protect over 1.5 million people in Nepal," U.S. Ambassador Randy Berry said at Kathmandu airport. The U.S. is also donating vaccines to several other Asian countries, including Indonesia, Malaysia and Thailand.news.yahoo.com
Johnson & Johnson's one-dose shot could be vital to vaccinating the rest of the country. But has it missed a critical moment?
"There have been interruptions, there have been concerns, and there's even been the pause," one state official said. "And because of that, it has at times really not lived up to that promise that we all would have liked here for the J&J vaccine."cbsnews.com
Miami Black leaders launch vaccine campaign to counter hesitancy after J&J pause
The impact of the two-week pause by federal health officials of the one-shot Johnson & Johnson vaccine is still being felt in the Liberty City area, where Congresswoman Frederica Wilson spoke Tuesday at the site of a makeshift cemetery memorializing the lives of Black Miami-Dade residents lost to COVID.news.yahoo.com
CDC panel needs more time to weigh risks of Johnson & Johnson's coronavirus vaccine
The CDC says it needs more time to weigh the risks of the Johnson & Johnson vaccine. An advisory panel met Wednesday but said it did not have enough information to make a decision, leaving a temporary pause on the vaccine in place. Dr. Amesh Adalja, an infectious disease expert and senior scholar at Johns Hopkins University's Bloomberg School of Public Health, joins CBSN's Lana Zak with more on the fate of the Johnson and Johnson vaccine.cbsnews.com
Johnson and Johnson COVID vaccine pause will slow efforts of vaccinating those in rural communities
The federal decision to temporarily pause the distribution of the Johnson and Johnson vaccine has implications in every health district in the Commonwealth, especially the smaller ones who planned to use the convenient one-dose shot to vaccinate their hard-to-reach residents.
CDC holds emergency meeting on Johnson & Johnson vaccine
The FDA and CDC are trying to determine whether the Johnson and Johnson vaccine is linked to a handful of blood clotting cases, one of them fatal. Tanya Rivero spoke with John Moore, a professor of microbiology and immunology at Weill Cornell Medical College, about the new concerns.cbsnews.com
CDC prepares to hold emergency meeting on Johnson and Johnson COVID-19 vaccine
The Centers for Disease Control and Prevention are preparing to hold an emergency meeting Tuesday to discuss the pause on the Johnson and Johnson vaccine, due to six cases of rare but severe blood clots. All 50 states have temporarily stopped use of these shots. CBS News' Laura Podesta joined "CBSN AM" with the latest.cbsnews.com
CDC prepares to hold emergency meeting on Johnson and Johnson COVID-19 vaccine
The Centers for Disease Control and Prevention are preparing to hold an emergency meeting Tuesday to discuss the pause on the Johnson and Johnson vaccine, due to six cases of rare but severe blood clots. All 50 states have temporarily stopped use of these shots. CBS News' Laura Podesta joins CBSN AM with the latest.cbsnews.com
Demand for Johnson and Johnson COVID-19 vaccine high in New River Valley
MONTGOMERY COUNTY, Va. – Health officials in the New River Valley are not getting as many doses of the Johnson and Johnson COVID-19 vaccine as expected. Health Director Dr. Noelle Bissell says people in the district have the most interest in the Johnson and Johnson vaccine. “We have a lot of people who have expressed interest in the Johnson and Johnson because it is a one-and-done shot. So we have a waitlist as soon as we get it that we can offer to people to come to a clinic that is Johnson and Johnson specific,” New River Health Director Dr. Noelle Bissell said. Bissell is still advising the community to get whatever vaccine becomes available first so the region can reach herd immunity against the virus.
Hotline to register 65 and older for the vaccine extended in Roanoke Valley
ROANOKE, Va. – While some areas are moving forward to Phase 1c with vaccine distribution, Roanoke Alleghany County Health District is still far from it. Waiting for more Johnson and Johnson vaccines, Dr. Cynthia Morrow said an extra 1,000 Moderna vaccines are expected to be added to the next shipment. A necessary supply as Morrow said a reduction of vaccine allocation from the state was not expected. “You know all of us were a little bit disappointed when we learned the state allocation was 49,000 not the over 100,000 we were expecting,” she said. That’s why on Wednesday a hotline was created to help register 65 and up.
Biden boosts US vaccine stockpile as world waits
White House aides said Biden’s first priority is ensuring that Americans are vaccinated before considering distributing doses elsewhere. AdRussia has sent millions of doses of its Sputnik V vaccine to countries around the world, even as it vaccinates its own population. Israel, which has vaccinated more than half of its population with Pfizer vaccines produced in Europe, has also attempted to use vaccine diplomacy to reward allies. Biden's purchasing strategy has come under criticism from nongovernmental organizations who have encouraged the White House to develop clear plans and thresholds for sharing vaccine with the world. So we’re not going to be ultimately safe until the world is safe,” acknowledged Biden.
Johnson & Johnson's one-shot Covid vaccine cleared for use in the EU
Athens City-County Health Department Director of Nursing, Crystal Jones, 52, loads syringes with the vaccine on the first day of the Johnson and Johnson vaccine. LONDON — The European Union on Thursday authorized the use of the one-dose coronavirus vaccine created by Johnson & Johnson, adding another weapon in the armory being used to fight Covid-19. Europe's drug regulator gave its recommendation earlier on Thursday with the EU Commission giving formal approval later in the day. Two-dose vaccines developed by Pfizer-BioNTech, Moderna and AstraZeneca and the University of Oxford have also been approved. While it's easier to distribute, the vaccine has not been found to be as effective as Pfizer and Moderna's shots at preventing Covid infection.cnbc.com
Biden doubles order of one-shot coronavirus vaccine
Biden doubles order of one-shot coronavirus vaccine The Biden administration is buying 200 million doses of the one-shot vaccine from Johnson & Johnson, meaning the U.S. could have a vaccine surplus by the end of the year. Nancy Cordes has the latest.cbsnews.com
Biden boosts US vaccine stockpile as world waits
(AP Photo/Andrew Harnik)WASHINGTON – President Joe Biden on Wednesday directed his administration to order another 100 million doses of the Johnson & Johnson coronavirus vaccine, growing a likely U.S. surplus of doses later this year when much of the rest of the world struggles with deep shortages. White House aides said that Biden’s first priority is ensuring that Americans are vaccinated before considering distributing doses elsewhere. Biden's purchasing strategy has come under criticism from nongovernmental organizations who have encouraged the White House to develop clear plans and thresholds for sharing vaccine with the world. “The only way to defeat this virus for good is to defeat it everywhere — and that requires an immediate plan for sharing excess vaccine doses globally,” said Sarah Swinehart, senior director for communications at The ONE Campaign. So we’re not going to be ultimately safe until the world is safe,” acknowledged Biden.
Detroit mayor rejects initial J&J vaccine shipment, saying Pfizer and Moderna are 'the best'
Detroit Mayor Mike Duggan rejected an initial allotment of the single-shot Johnson & Johnson Covid-19 vaccine this week, according to the Michigan state health department. While some have raised concern over the J&J vaccine's lower efficacy rate, the J&J vaccine has proven to prevent 100% of virus-related hospitalizations and deaths, according to its clinical trial data. He is very eager for the Johnson & Johnson vaccine. "As vaccine eligibility expands, Detroit will open a second site offering Johnson & Johnson vaccines. I have full confidence that the Johnson & Johnson vaccine is both safe and effective."cnbc.com
Expert weighs in on double masks and the Johnson & Johnson shot
Expert weighs in on double masks and the Johnson & Johnson shot Some people are skeptical of getting the new Johnson & Johnson COVID-19 shot because of its efficacy rate or because of moral objections. Dr. Bob Lahita joined CBSN with what the science says about the vaccines, whether to wear two masks and more.cbsnews.com
Canada clears Johnson & Johnson vaccine, first to approve 4
FILE - This Dec. 2, 2020, file photo provided by Johnson & Johnson shows vials of the COVID-19 vaccine in the United States. The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday, Feb. 27, 2021 cleared a Johnson & Johnson shot that works with just one dose instead of two (Johnson & Johnson via AP)TORONTO, ONT – Canada is getting a fourth vaccine to prevent COVID-19 as the country's health regulator has cleared a Johnson & Johnson shot that works with just one dose instead of two, officials said Friday. Prime Minister Justin Trudeau said Canada has an agreement with Johnson & Johnson for 10 million doses before September. Trudeau said officials have been assured by the European Union that Pfizer and Moderna vaccine deliveries to Canada won't be disrupted. He said Canada won't get AstraZeneca vaccines doses from Europe for months.
All Virginians who want a COVID vaccine will likely have their first dose by the end May
ROANOKE, Va – Virginia’s top vaccine expert said everyone in the commonwealth who wants a COVID-19 vaccine should be able to get their first shot by the end of May. Dr. Danny Avula with the Virginia Department of Health said Virginia continues to get increased amounts of Moderna, Pfizer, and now the Johnson & Johnson vaccine. Avula said that by the end of the month, VDH will be getting 500,000 doses of the vaccine a week and 650,000 doses a week by the end of April. “It’s very realistic to say that everybody in 1b, who wants to get vaccinated will be able to do that by the end of April, and everybody across the board who wants to get vaccinated, was able to get their first dose by the end of May,” said Avula. The VDH will also start hosting more large-scale vaccination events starting later this week to distribute the Johnson & Johnson vaccine.
Biden ramps up COVID-19 vaccine production as states start lifting restrictions
Biden ramps up COVID-19 vaccine production as states start lifting restrictions To help ramp up vaccination efforts, the pharmaceutical company Merck has agreed to help mass-produce Johnson and Johnson's single-dose coronavirus vaccine. President Biden now says there will be enough doses for every adult in the country by the end of May. CBS News correspondent Janet Shamlian reports from Houston, and Dr. Dara Kass, an ER doctor and medical contributor for Yahoo News, joins CBSN's Elaine Quijano to discuss the latest.cbsnews.com
Expert weighs in on Johnson & Johnson's one-dose COVID-19 vaccine
Expert weighs in on Johnson & Johnson's one-dose COVID-19 vaccine The third coronavirus vaccine to receive emergency-use authorization from the Food and Drug Administration is being rolled out across the U.S. Medical trials found the Johnson and Johnson vaccine is 85% effective against severe illness. John Moore, a professor of microbiology and immunology at Weill Cornell Medical College, joined CBSN to discuss.cbsnews.com
Eye Opener: FDA greenlights Johnson & Johnson COVID-19 vaccine
Eye Opener: FDA greenlights Johnson & Johnson COVID-19 vaccine The FDA has granted emergency use authorization for Johnson and Johnson's single-shot COVID-19 vaccine. Also, former President Trump signaled a possible 2024 White House run. All that and all that matters in today's Eye Opener. Your world in 90 seconds.cbsnews.com
FDA and CDC advisory panel approve third coronavirus vaccine for Americans
FDA and CDC advisory panel approve third coronavirus vaccine for Americans Which vaccine is the most effective against the coronavirus? The Moderna and Pfizer vaccines require two shots to be fully vaccinated. However, the new Johnson and Johnson vaccine uses a one-shot method and is easier to store. CBS News researcher Max Bayer joins CBSN's Land Zak to discuss the difference between the vaccines, their efficacy against variants, and if pregnant women should be vaccinated.cbsnews.com
Johnson & Johnson COVID-19 vaccine could be in Roanoke Valley as soon as next week
ROANOKE, Va – If the Johnson & Johnson COVID-19 vaccine is approved, it could be in the Roanoke Valley as early as next week. The vaccine is on the verge of getting emergency approval from the Food and Drug Administration. Studies show the single-shot vaccine would be 66% effective against moderate and severe cases of COVID-19. Roanoke City and Alleghany Health District Director Dr. Cynthia Morrow says the department will likely administer the shot on different days during its clinics. The department will likely get a small amount at first and then increased doses as time goes on similar to Moderna and Pfizer.
Johnson and Johnson vaccine could be key to the distribution slowdown
ROANOKE, Va. – With the U.S. Food and Drug Administration deeming the Johnson and Johnson safe to use and effective, it could be key to helping solve the distribution dilemma in the Commonwealth. Despite the Johnson and Johnson vaccine being 66% effective, Dr. Noelle Bissell, the director for the New River Health District, said it will work. “We say this every year about flu vaccinations. Even flu vaccinations are not even that high.”Requiring standard refrigeration temperatures, Bissell said the vaccine is a more convenient dose to deliver and administer. “The Johnson and Johnson works very well if you are going to do a big drive-thru event because again it’s a one-time dose,” she said.
Developing world lagging behind in effort to inoculate populations
Developing world lagging behind in effort to inoculate populations South Africa has launched its mass COVID-19 vaccination campaign with the shot developed by Johnson & Johnson, which has not been approved for use anywhere in the world. The move underscores the desperation in the developing world to fight the coronavirus. Debora Patta reports.cbsnews.com
Doctor discusses testing for COVID-19 variants and Johnson & Johnson's vaccine
Doctor discusses testing for COVID-19 variants and Johnson & Johnson's vaccine A third coronavirus vaccine could be available in the U.S. by the end of the month. Johnson and Johnson has asked the Food and Drug Administration to authorize its vaccine for emergency use. "CBS This Morning" lead national correspondent David Begnaud reports several of the new variants of the virus are spreading, and CBSN's Tanya Rivero spoke with infectious disease specialist Dr. Uzma Syed, director of the Antimicrobial Stewardship Center of Excellence at Good Samaritan Hospital Medical Center in New York.cbsnews.com
Eye Opener: Johnson & Johnson requests FDA approval for single-shot vaccine
Eye Opener: Johnson & Johnson requests FDA approval for single-shot vaccine Pharmaceutical company Johnson & Johnson is asking the FDA to grant emergency use authorization for its single-shot coronavirus vaccine. Also, former President Trump has rejected a request by House Democrats to testify under oath at his second impeachment trial. All that and all that matters in today's Eye Opener. Your world in 90 seconds.cbsnews.com
Johnson and Johnson finds COVID-19 vaccine 85% effective against severe cases
Johnson and Johnson finds COVID-19 vaccine 85% effective against severe cases Johnson and Johnson's single shot COVID-19 vaccine is bringing new hope in the race to vaccinate Americans. Trials showed the vaccine largely prevented moderate and severe cases. Mola Lenghi has the latest.cbsnews.com
Johnson & Johnson and Novavax COVID vaccines offer promising results
Johnson & Johnson and Novavax COVID vaccines offer promising results Pharmaceutical company Johnson and Johnson says its single-shot coronavirus vaccine has proven effective at preventing severe illness in clinical trials. This comes as a new variant of the virus, originally seen in South Africa, has surfaced in the U.S. CBS News' Mola Lenghi reports, and Dr. Annette Reboli of Cooper Medical School of Rowan University joins CBSN's Tanya Rivero to discuss the latest developments.cbsnews.com
Vaccine makers work to take on coronavirus variants
Vaccine makers work to take on coronavirus variants Johnson and Johnson has reported promising results from its single-dose coronavirus vaccine and plans to apply for emergency use authorization in early February. Meanwhile, the virus variant first identified in South Africa has now been found in the United States. CBS News' Mola Lenghi reports, and Dr. Bob Lahita spoke with CBSN's Anne-Marie Green and Vladimir Duthiers about the highly contagious new strain and the work drugmakers are doing to fight variants that continue to appear.cbsnews.com
Earnings season is a critical test for a stock market on the road back to a record
Its stock rose 1.9% in Tuesday's premarket to $104.40 a share, after its earnings beat. Since the pandemic, companies have provided various amounts of visibility into their businesses, but many companies have still not provided guidance. Deutsche Bank said second-quarter earnings beat at an unprecedented rate of 85%. On just an earnings beat, the stock traded higher just half the time — and on average gained 4.22% to the next earnings report," Birinyi said. Some of the companies that have not yet provided guidance include Illinois Toolworks, IDEXX, Union Pacific, Mastercard, and Intuitive Surgical.cnbc.com
Johnson & Johnson to stop selling talc-based Johnson's Baby Powder in U.S., Canada
FILE PHOTO: Bottles of Johnson's baby powder are displayed in a store in New York City, U.S., January 22, 2019. REUTERS/Brendan McDermid/File Photo(Reuters) - Johnson and Johnson on Tuesday said it would stop selling its talc-based Johnsons Baby Powder in the United States and Canada as part of a broad reassesment of its consumer product portfolio prompted by the COVID-19 pandemic. J&J faces lawsuits from consumers claiming its talc products, including Johnsons Baby Powder, caused their cancer, but J&J said it remains confident in the products safety. (This story has been refiled to fix story number)feeds.reuters.com
Johnson & Johnson confirms no asbestos in Johnson's Baby Powder
A container of Johnson's baby powder made by Johnson and Johnson sits on a table on October 18, 2019 in San Anselmo, California. Johnson & Johnson said on Tuesday that more tests showed that Johnson's Baby Powder was free of asbestos after U.S. Food and Drug Administration investigations had found trace amounts of the material. The voluntary recall was limited to one lot of Johnson's Baby Powder produced and shipped in the United States in 2018, the company said at the time. That move marked the first time the company recalled its baby powder for possible asbestos contamination, and the first time U.S. regulators have announced a finding of asbestos in the product. J&J faces more than 15,000 lawsuits from consumers claiming its talc products, including Johnson's Baby Powder, caused their cancer.cnbc.com
Walmart, CVS, Rite Aid pull J&J baby powder from shelves after FDA finds sub-trace levels of asbestos
In this photo illustration, a container of Johnson's baby powder made by Johnson and Johnson sits on a table on July 13, 2018 in San Francisco, California. Walmart, CVS Health and Rite Aid are pulling all containers of Johnson & Johnson's 22-ounce baby powder after the FDA found sub-trace amounts of asbestos, the companies confirmed Thursday. "CVS Pharmacy is complying with Johnson & Johnson's voluntary recall of Johnson's Baby Powder 22 oz. Walmart, the world's largest retailer, said it removed and blocked all of the recalled baby powder, as did Rite Aid. Last week, J&J voluntarily recalled an estimated 33,000 bottle of its 22-ounce baby powder.cnbc.com
Stocks making the biggest moves midday: Johnson & Johnson, Coca-Cola, L Brands & more
In this photo illustration, a container of Johnson's baby powder made by Johnson and Johnson sits on a table on July 13, 2018 in San Francisco, California. Intuitive Surgical Intuitive Surgical popped more than 5.5% after it reported quarterly profit of $3.43 per share, beating consensus estimates. The designer of robotic surgical devices saw sales beat estimates, with procedures involving its flagship Da Vinci growing nearly 20% on a year-over-year basis. Johnson & Johnson The Dow component's stock fell more than 4% on news the company is recalling baby powder after discovering traces of asbestos in it. Johnson & Johnson also said it is working with the Food and Drug Administration in its investigation on the matter.cnbc.com
Oklahoma judge miscalculated judgment in opioid case
OKLAHOMA CITY, Okla. - The Oklahoma judge who recently ordered pharmaceutical giant Johnson & Johnson to pay $572 million for its role in the state's opioid crisis says he made a mathematical error when calculating the judgment. As part of the landmark verdict in August, Judge Thad Balkman set aside $107,683,000 to help combat neonatal abstinence syndrome, or NAS. On Tuesday, Balkman agreed with Johnson and Johnson regarding the error. The judge still needs to decide if the court will continue to monitor the opioid crisis for the next 20 years and potentially award more money to the state. Johnson & Johnson has already indicated they will appeal any decision.
Johnson & Johnson faces a crucial hearing Monday over thousands of talc baby powder lawsuits
In this photo illustration, a container of Johnson's baby powder made by Johnson and Johnson sits on a table on July 13, 2018 in San Francisco, California. Johnson & Johnson will make its case to dismiss thousands of lawsuits alleging its talc-based baby powder causes ovarian cancer in a crucial hearing starting Monday. The company faces more than 14,000 lawsuits claiming its baby powder caused ovarian cancer and mesothelioma. J&J is challenging the plaintiffs' witnesses scientific principles and arguing they cannot prove baby powder causes cancer. The company wants Wolfson to dismiss all of the plaintiffs' 22 witnesses and dismiss the cases.cnbc.com
MoneyWatch: Target cuts jobs; Johnson and Johnson subsidiary pleads guilty
MoneyWatch: Target cuts jobs; Johnson and Johnson subsidiary pleads guilty The retail giant cuts 1700 jobs at its Minneapolis headquarters, citing efficiency. And, a subsidiary of Johnson and Johnson agrees to pay 25 million dollars after pleading guilty to a criminal charge of selling bottles with metal particles inside. Wendy Gillette reports on the day's top MoneyWatch headlines.cbsnews.com